April 30, 2015
The Ministry of Health, Labor and Welfare issued a pharmaceutical safety information bulletin on April 28, notifying physicians that thrombocytopenia has been added to the list of clinically significant adverse reactions in the package inserts for the DPP-4 inhibitor sitagliptin...read more